Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jule Kortendieck

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Theranostics|September 6, 2024
In-depth cross-validation of human and mouse CD4-specific minibodies for noninvasive PET imaging of CD4<sup>+</sup> cells and response prediction to cancer immunotherapyStefania Pezzana, Simone Blaess, Jule Kortendieck, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Theranostics|September 6, 2024
In-depth cross-validation of human and mouse CD4-specific minibodies for noninvasive PET imaging of CD4<sup>+</sup> cells and response prediction to cancer immunotherapyStefania Pezzana, Simone Blaess, Jule Kortendieck, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 1